Tuesday, July 19, 2016

Monsanto also has higher Bayer offer back – Bayer ‘disappointed’ – ABC Online

Tuesday , 07.19.2016, 19:21
Thank you for rating!

0

Report Error
You have an error found?

Please select the relevant words in the text. With just two clicks you report the error of the editors.

The billion Poker Bayer and Monsanto continues: the US seed producer also holds the increased multibillion takeover bid of the German pharmaceutical and agricultural chemical company for too low

the offer is not sufficient financially to ensure a business. , Monsanto announced in St. Louis on Tuesday. But Monsanto remains open to discussions with the Leverkusen-based company and other parties, it said.

Bayer was disappointed in the evening of the new Monsanto dissipation. The offer to the shareholders of Monsanto corresponds to a premium of 40 percent to Monsanto’s closing price before the offer, reaffirmed Leverkusen. The matching offer is a compelling opportunity for immediate and safe appreciation for Monsanto shareholders, especially in the light of recent poor business performance and reduced medium-term outlook of Monsanto. There was also no financing condition

However, Bayer gave himself gespächsbereit. Bayer see a continuation of the dialogue with appropriate confidentiality agreement to the contrary, which enables access to further information, it was in the evening

<. p> WORKS NEEDED INDOOR DECISION oN

Bayer had raised slightly its offer last week from 122 to 125 US dollars per share. The record-offer increased from 62 billion to a total of around 64 billion dollars. On the market, it is assumed that the Germans wanted the Americans to move in this way to provide insight into the books. This would facilitate Bayer, to get an accurate picture of the value of the US company. Analysts expect that the doors could probably open from around 130 dollars.

The head of the Central Bayer, Oliver Zühlke, warned meanwhile a speedy decision on. “The faster the takeover battle is decided, the better. Each new message take the speculation in the Group “, Zühlke told the” Rheinische Post “(Wednesday edition). A further increase of the offer is for the Executive Board. This knew what he could expect the Group financially. “Strategically, the acquisition makes sense”, Zühlke.

BAYER PROMOTES THE OFFER

Bayers originating offer said totaled $ 62 billion, including the debt of Monsanto. Bayer provides Monsanto beyond a so-called break fee of $ 1.5 billion in case the antitrust approvals should not be granted. The increase recorded Bayer made possible after the company had received in confidential discussions with Monsanto additional information, it said last Thursday. Bayer have the firm intention to complete this transaction, it was said at the time.

The Leverkusen had surprisingly announced the proposed acquisition of seed specialists from the United States in May. The German company would rise through the record-merger the world’s number one in the agricultural chemicals business. Nevertheless, the deal was controversial from the start. Monsanto is in Europe for years because of its genetically modified products in the review

CRITICISM OF MONSANTO

The US manufacturers of genetically modified seeds is under accused others ruppiges behavior in dealing with its customers. In addition, Monsanto sells the weedkiller glyphosate. This is suspected to be carcinogenic. Monsanto marketed glyphosate under the name Roundup. Recently, the EU Commission had extended the European approval of the controversial weed shredder by up to 18 months.

Monsanto According circles recently talking with the Bayer competitors BASF through a combination of the respective agrochemical divisions resumed. The Americans tested various transactions including the acquisition of BASF’s business with solutions for the agricultural economy, the news agency Bloomberg had about a week ago, citing reports with the matter people.

A LOT OF MOVEMENT IN THE INDUSTRY

in the industry generally much in motion: How will the Swiss agricultural chemicals supplier Syngenta swallow for about $ 43 billion of Chinese chemical company ChemChina. The US rival Dow Chemical and Dupont want to go together. They would thus once the industry leader BASF dethrone. However, the two US corporations want to split following the proposed merger in three listed companies.

 

Thank you for rating!

0

LikeTweet

No comments:

Post a Comment